This HTML5 document contains 51 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n12http://dx.doi.org/10.1200/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q93515282
rdf:type
wikibase:Item
schema:description
article by M Kaufmann et al published 1 August 1989 in Journal of Clinical Oncology наукова стаття article scientifique publié en 1989 wetenschappelijk artikel
p:P577
wds:Q93515282-C5E47EF5-6038-4A6F-BD59-BB62A7B5FFBF
wdt:P577
1989-08-01T00:00:00Z
p:P2093
wds:Q93515282-BBE38D88-C324-450E-8330-0C8870BBB00C wds:Q93515282-CE5C4B6B-33B8-43B9-8BDC-FF490A605236 wds:Q93515282-C9505174-9A7F-45F1-8F66-07575EAC2B18 wds:Q93515282-6A1CC0C3-446C-4505-8F01-B741DE592B12 wds:Q93515282-4A736937-75DD-4ED8-99D0-921BD75E5282 wds:Q93515282-905A43CA-100B-43E2-8576-D387E95227B5 wds:Q93515282-A01D86D7-4CD1-46D4-AE21-ECBCF321936C wds:Q93515282-0E16B3C4-FA7F-4F3D-B525-939417E82962 wds:Q93515282-EDF5D042-427D-401B-8D24-AC6047728083 wds:Q93515282-AFA4BCFC-7299-42A9-BB03-A74B6F3DCD27
wdt:P2093
F Jänicke W Eiermann W Jonat H K Weitzel R Kreienberg M Kaufmann J Hilfrich M Albrecht H Schmid U Kleeberg
rdfs:label
Goserelin, a depot gonadotrophin-releasing hormone agonist in the treatment of premenopausal patients with metastatic breast cancer. German Zoladex Trial Group Goserelin, a depot gonadotrophin-releasing hormone agonist in the treatment of premenopausal patients with metastatic breast cancer. German Zoladex Trial Group
skos:prefLabel
Goserelin, a depot gonadotrophin-releasing hormone agonist in the treatment of premenopausal patients with metastatic breast cancer. German Zoladex Trial Group Goserelin, a depot gonadotrophin-releasing hormone agonist in the treatment of premenopausal patients with metastatic breast cancer. German Zoladex Trial Group
schema:name
Goserelin, a depot gonadotrophin-releasing hormone agonist in the treatment of premenopausal patients with metastatic breast cancer. German Zoladex Trial Group Goserelin, a depot gonadotrophin-releasing hormone agonist in the treatment of premenopausal patients with metastatic breast cancer. German Zoladex Trial Group
p:P1476
wds:Q93515282-26CDFCFB-55C2-4382-B6EF-3C22D81C6DEC
wdt:P1476
Goserelin, a depot gonadotrophin-releasing hormone agonist in the treatment of premenopausal patients with metastatic breast cancer. German Zoladex Trial Group
p:P304
wds:Q93515282-A32383F7-4876-481C-8532-9DF1602FD980
wdt:P304
1113-1119
p:P31
wds:Q93515282-817DC1ED-3C53-4FE8-A2CB-217448AEBD72
wdt:P31
wd:Q13442814
p:P698
wds:Q93515282-D4B58C95-B26D-401B-86A1-769668BB2B50
wdtn:P698
n10:2526863
wdt:P698
2526863
p:P1433
wds:Q93515282-A025B15D-D91A-4624-AA18-3052B229003B
wdt:P1433
wd:Q400292
p:P433
wds:Q93515282-67F85B64-50B4-472B-A6FC-1A02FCFB2D52
p:P478
wds:Q93515282-0D159B93-74CE-43B2-8D78-2F865C1B93E3
wdt:P433
8
wdt:P478
7
p:P356
wds:Q93515282-74402C89-670B-48D1-A448-A578797E0153
wdtn:P356
n12:JCO.1989.7.8.1113
wdt:P356
10.1200/JCO.1989.7.8.1113